These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27155029)

  • 21. Safety of antisense oligonucleotide and siRNA-based therapeutics.
    Chi X; Gatti P; Papoian T
    Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense molecules for targeted cancer therapy.
    Wacheck V; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
    Mirabelli CK; Bennett CF; Anderson K; Crooke ST
    Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligonucleotide-Based Therapies for Inflammatory Bowel Disease.
    Bevivino G; Sedda S; Marafini I; Monteleone G
    BioDrugs; 2018 Aug; 32(4):331-338. PubMed ID: 29948918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic perspectives on antisense oligonucleotides].
    Mazza P
    Boll Chim Farm; 1992 Nov; 131(10):355-62. PubMed ID: 1296702
    [No Abstract]   [Full Text] [Related]  

  • 26. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense strategies for oncogene inactivation.
    Stein CA; Benimetskaya L; Mani S
    Semin Oncol; 2005 Dec; 32(6):563-72. PubMed ID: 16338422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense therapy in oncology: new hope for an old idea?
    Tamm I; Dörken B; Hartmann G
    Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense oligonucleotides, aptamers and SiRNA: promises for the treatment of ocular diseases.
    Fattal E; Bochot A
    Arch Soc Esp Oftalmol; 2006 Jan; 81(1):3-4, 5-6. PubMed ID: 16450253
    [No Abstract]   [Full Text] [Related]  

  • 31. From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.
    Gioia SD; Sardo C; Castellani S; Porsio B; Belgiovine G; Carbone A; Giammona G; Cavallaro G; Conese M
    Curr Drug Deliv; 2017; 14(2):253-271. PubMed ID: 27557670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of antisense nucleic acid molecules.
    Opalinska JB; Gewirtz AM
    Sci STKE; 2003 Oct; 2003(206):pe47. PubMed ID: 14583589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New developments in antiviral chemotherapy].
    Doerr HW; Preiser W; Weber B
    Immun Infekt; 1993 Dec; 21(6):171-6. PubMed ID: 8144182
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of Antisense Drugs for Dyslipidemia.
    Yamamoto T; Wada F; Harada-Shiba M
    J Atheroscler Thromb; 2016 Sep; 23(9):1011-25. PubMed ID: 27466159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense therapy and emerging applications for the management of dyslipidemia.
    Toth PP
    J Clin Lipidol; 2011; 5(6):441-9. PubMed ID: 22108147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisense drug discovery and development.
    Yamamoto T; Nakatani M; Narukawa K; Obika S
    Future Med Chem; 2011 Mar; 3(3):339-65. PubMed ID: 21446846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Bcl-2 family in cancer therapy.
    Papadopoulos K
    Semin Oncol; 2006 Aug; 33(4):449-56. PubMed ID: 16890799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent review: therapeutic applications for antisense oligonucleotides 1999-2000.
    Orr RM; O'Neill CF
    Curr Opin Mol Ther; 2000 Jun; 2(3):325-31. PubMed ID: 11249627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic acid-based drugs against emerging zoonotic viruses.
    Wong JP
    Future Med Chem; 2015; 7(13):1709-19. PubMed ID: 26399689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.